Cargando…
Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
Gliomas are the most fatal malignant cerebral tumors. Temozolomide (TMZ), as the primary chemotherapy drug, has been widely used in clinics. However, resistance of TMZ still remains to poor defined. LncRNAs have been reported to play crucial roles in progression of various cancers and resistance of...
Autores principales: | Lv, Qiao-Li, Wang, Li-Chong, Li, Dang-Chi, Lin, Qian-Xia, Shen, Xiao-Li, Liu, Hai-Yun, Li, Min, Ji, Yu-Long, Qin, Chong-Zhen, Chen, Shu-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756250/ https://www.ncbi.nlm.nih.gov/pubmed/33362537 http://dx.doi.org/10.3389/fphar.2020.560543 |
Ejemplares similares
-
Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
por: Zhao, Zijin, et al.
Publicado: (2021) -
Identification of lncRNA DLEU2 as a potential diagnostic biomarker and anti-inflammatory target for ulcerative colitis
por: Lin, Qiuling, et al.
Publicado: (2022) -
Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy
por: Sun, Wei, et al.
Publicado: (2017) -
Knockdown of LncRNA DLEU2 Inhibits Cervical Cancer Progression via Targeting miR-128-3p
por: Wang, Bofei, et al.
Publicado: (2020) -
Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux
por: Wen, Zhi-peng, et al.
Publicado: (2019)